PortfoliosLab logoPortfoliosLab logo
CALM vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CALM vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cal-Maine Foods, Inc. (CALM) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CALM achieves a -0.54% return, which is significantly higher than NVO's -10.74% return. Over the past 10 years, CALM has outperformed NVO with an annualized return of 9.86%, while NVO has yielded a comparatively lower 7.56% annualized return.


CALM

1D
-2.22%
1M
-1.77%
YTD
-0.54%
6M
-8.91%
1Y
-13.33%
3Y*
23.34%
5Y*
22.16%
10Y*
9.86%

NVO

1D
-0.18%
1M
-6.80%
YTD
-10.74%
6M
-9.50%
1Y
-43.34%
3Y*
-15.59%
5Y*
2.92%
10Y*
7.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CALM vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CALM
Cal-Maine Foods, Inc.
-0.54%-15.61%87.00%14.48%51.87%-1.38%-12.19%2.09%-3.90%0.62%
NVO
Novo Nordisk A/S
-10.74%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between CALM and NVO is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.05

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Dec 12, 1996

0.12

The correlation between CALM and NVO shifts across timeframes, from -0.03 (1 year) to 0.12 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CALM:

$3.70B

NVO:

$195.21B

EPS

CALM:

$14.48

NVO:

DKK 27.42

PE Ratio

CALM:

5.39

NVO:

10.34

PEG Ratio

CALM:

0.00

NVO:

0.44

PS Ratio

CALM:

1.08

NVO:

3.85

PB Ratio

CALM:

1.37

NVO:

6.21

Total Revenue (TTM)

CALM:

$3.46B

NVO:

DKK 327.80B

Gross Profit (TTM)

CALM:

$1.17B

NVO:

DKK 268.30B

EBITDA (TTM)

CALM:

$1.05B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CALM vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CALM
CALM Risk / Return Rank: 2727
Overall Rank
CALM Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
CALM Sortino Ratio Rank: 2323
Sortino Ratio Rank
CALM Omega Ratio Rank: 2424
Omega Ratio Rank
CALM Calmar Ratio Rank: 3131
Calmar Ratio Rank
CALM Martin Ratio Rank: 3333
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CALM vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cal-Maine Foods, Inc. (CALM) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CALMNVODifference
Sharpe ratioReturn per unit of total volatility

+0.43

Sortino ratioReturn per unit of downside risk

+0.66

Omega ratioGain probability vs. loss probability

0.95

0.85

+0.10

Calmar ratioReturn relative to maximum drawdown

-0.36

-0.80

+0.44

Martin ratioReturn relative to average drawdown

-0.56

-1.18

+0.62

CALM vs. NVO - Sharpe Ratio Comparison

The current CALM Sharpe Ratio is -0.41, which is higher than the NVO Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of CALM and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CALM vs. NVO - Drawdown Comparison

The maximum CALM drawdown since its inception was -74.08%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for CALM and NVO.


Loading charts...

Drawdown Indicators


CALMNVODifference

Max Drawdown

Largest peak-to-trough decline

-74.08%

-74.70%

+0.62%

Max Drawdown (1Y)

Largest decline over 1 year

-37.00%

-54.34%

+17.34%

Max Drawdown (3Y)

Largest decline over 3 years

-37.00%

-74.70%

+37.70%

Max Drawdown (5Y)

Largest decline over 5 years

-37.00%

-74.70%

+37.70%

Max Drawdown (10Y)

Largest decline over 10 years

-39.12%

-74.70%

+35.58%

Current Drawdown

Current decline from peak

-31.17%

-68.11%

+36.94%

Average Drawdown

Average peak-to-trough decline

-30.31%

-17.79%

-12.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.95%

37.62%

-13.67%

Volatility

CALM vs. NVO - Volatility Comparison

The current volatility for Cal-Maine Foods, Inc. (CALM) is 6.31%, while Novo Nordisk A/S (NVO) has a volatility of 10.68%. This indicates that CALM experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CALMNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

6.31%

10.68%

-4.37%

Volatility (6M)

Calculated over the trailing 6-month period

20.43%

38.04%

-17.61%

Volatility (1Y)

Calculated over the trailing 1-year period

33.03%

51.88%

-18.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.61%

38.33%

-5.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.13%

32.56%

-1.43%

Dividends

CALM vs. NVO - Dividend Comparison

CALM's dividend yield for the trailing twelve months is around 6.15%, more than NVO's 4.11% yield.


PositionTTM20252024202320222021202020192018201720162015
CALM
Cal-Maine Foods, Inc.
6.15%10.90%2.82%7.51%3.17%0.09%0.00%0.98%1.03%0.00%2.70%4.10%
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

CALM vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Cal-Maine Foods, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
666.95M
96.82B
(CALM) Total Revenue
(NVO) Total Revenue
Please note, different currencies. CALM values in USD, NVO values in DKK

CALM vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Cal-Maine Foods, Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
17.9%
86.0%
Portfolio components
CALM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported a gross profit of 119.28M and revenue of 666.95M. Therefore, the gross margin over that period was 17.9%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

CALM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported an operating income of 35.98M and revenue of 666.95M, resulting in an operating margin of 5.4%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

CALM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported a net income of 50.46M and revenue of 666.95M, resulting in a net margin of 7.6%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


CALM and NVO have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVO has higher volatility (10.68%) compared to CALM (6.31%). In terms of maximum drawdown, CALM dropped -74.08% vs NVO's -74.70%.

CALM currently has the higher Sharpe Ratio (-0.41 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CALM and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer